+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
Age: 65Years +
All Genders
ID06998069

Study of Tailored Reduced Intensity Chemoimmunotherapy and Radiation in Frail Older Adults with Stage IB-IVA Head and Neck Squamous Cell Carcinoma

Led by Brown University · Updated on 2026-08-20

20

Participants Needed

1

Research Sites

26 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating a novel treatment approach for patients aged 65 and older diagnosed with stage IB-IVA squamous cell carcinoma of the head and neck. The study focuses on those classified as frail based on a comprehensive geriatric assessment CGA score between 3 and 5. This Phase 3 trial aims to tailor treatment intensity based on the programmed cell death ligand 1 combined positive score PD-L1 CPS. Participants receive one of three treatment regimens depending on their PD-L1 CPS score. These regimens include combinations of carboplatin, paclitaxel, pembrolizumab, cetuximab, and radiation therapy. Each treatment cycle occurs every 21 days for four cycles, followed by one week of radiation therapy delivering 30Gy. The treatment is adapted to individual biomarker profiles to assess the feasibility of a reduced intensity regimen in this frail geriatric population. Throughout the study, participants undergo assessments including treatment completion over approximately 14 weeks, overall response rate evaluation about 12 weeks after treatment, and long-term monitoring of disease-free and overall survival for up to three years. Toxicity is assessed about 30 days after completion of treatment. Patients are closely monitored with standard clinical evaluations, imaging studies, and laboratory tests to measure both safety and treatment outcomes.

CONDITIONS

Brief Title

Head and Neck Cancer Study Project in the Geriatric Population

Research Team

B

BrUOG

I

Iole Ribizzi-Akhtar, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here